Gorjan Hrustanovic

870 total citations
8 papers, 415 citations indexed

About

Gorjan Hrustanovic is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Gorjan Hrustanovic has authored 8 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Gorjan Hrustanovic's work include Lung Cancer Treatments and Mutations (3 papers), RNA modifications and cancer (2 papers) and Cancer Mechanisms and Therapy (2 papers). Gorjan Hrustanovic is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), RNA modifications and cancer (2 papers) and Cancer Mechanisms and Therapy (2 papers). Gorjan Hrustanovic collaborates with scholars based in United States and Germany. Gorjan Hrustanovic's co-authors include Trever G. Bivona, Bianca J. Lee, Victor Olivas, Saurabh Asthana, Collin M. Blakely, Evangelos Pazarentzos, Matthew A. Gubens, Ghiabe-Henri Guibinga, Timothy Fouts and W. H. Newton and has published in prestigious journals such as Nature Genetics, Oncogene and Human Molecular Genetics.

In The Last Decade

Gorjan Hrustanovic

8 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gorjan Hrustanovic United States 8 279 167 137 114 40 8 415
Alessandra Dall’Acqua Italy 10 270 1.0× 157 0.9× 92 0.7× 109 1.0× 31 0.8× 16 410
Sourik S. Ganguly United States 10 244 0.9× 142 0.9× 74 0.5× 81 0.7× 40 1.0× 15 403
Wenfei Ji China 8 266 1.0× 198 1.2× 106 0.8× 180 1.6× 21 0.5× 9 419
Reyno Del Rosario United States 10 325 1.2× 171 1.0× 76 0.6× 127 1.1× 30 0.8× 11 476
Silvia Pomella Italy 14 511 1.8× 129 0.8× 122 0.9× 114 1.0× 30 0.8× 29 644
Jorg Michels Canada 8 280 1.0× 151 0.9× 91 0.7× 71 0.6× 47 1.2× 14 451
Kevin S. Quackenbush United States 12 228 0.8× 219 1.3× 71 0.5× 112 1.0× 47 1.2× 17 423
Weifei Fan China 14 279 1.0× 135 0.8× 77 0.6× 174 1.5× 44 1.1× 25 434
Sang-Hyun Song South Korea 14 512 1.8× 215 1.3× 97 0.7× 125 1.1× 53 1.3× 18 644
Mehlika Hazar-Rethinam Australia 11 321 1.2× 173 1.0× 67 0.5× 102 0.9× 21 0.5× 16 428

Countries citing papers authored by Gorjan Hrustanovic

Since Specialization
Citations

This map shows the geographic impact of Gorjan Hrustanovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gorjan Hrustanovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gorjan Hrustanovic more than expected).

Fields of papers citing papers by Gorjan Hrustanovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gorjan Hrustanovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gorjan Hrustanovic. The network helps show where Gorjan Hrustanovic may publish in the future.

Co-authorship network of co-authors of Gorjan Hrustanovic

This figure shows the co-authorship network connecting the top 25 collaborators of Gorjan Hrustanovic. A scholar is included among the top collaborators of Gorjan Hrustanovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gorjan Hrustanovic. Gorjan Hrustanovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Okimoto, Ross A., Frank Breitenbuecher, Victor Olivas, et al.. (2016). Inactivation of Capicua drives cancer metastasis. Nature Genetics. 49(1). 87–96. 117 indexed citations
2.
Hrustanovic, Gorjan & Trever G. Bivona. (2016). RAS signaling in ALK fusion lung cancer. Small GTPases. 7(1). 32–33. 8 indexed citations
3.
Blakely, Collin M., Evangelos Pazarentzos, Victor Olivas, et al.. (2015). NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer. Cell Reports. 11(1). 98–110. 143 indexed citations
4.
Pazarentzos, Evangelos, Petros Giannikopoulos, Gorjan Hrustanovic, et al.. (2015). Oncogenic activation of the PI3-kinase p110β isoform via the tumor-derived PIK3CβD1067V kinase domain mutation. Oncogene. 35(9). 1198–1205. 34 indexed citations
5.
Hrustanovic, Gorjan & Trever G. Bivona. (2015). RAS-MAPK signaling influences the efficacy of ALK-targeting agents in lung cancer. Molecular & Cellular Oncology. 3(2). e1091061–e1091061. 10 indexed citations
6.
Guibinga, Ghiabe-Henri, et al.. (2013). Deficiency of the purine metabolic gene HPRT dysregulates microRNA-17 family cluster and guanine-based cellular functions: a role for EPAC in Lesch-Nyhan syndrome. Human Molecular Genetics. 22(22). 4502–4515. 14 indexed citations
7.
Hrustanovic, Gorjan, Bianca J. Lee, & Trever G. Bivona. (2013). Mechanisms of resistance to EGFR targeted therapies. Cancer Biology & Therapy. 14(4). 304–314. 53 indexed citations
8.
Guibinga, Ghiabe-Henri, et al.. (2011). MicroRNA-mediated dysregulation of neural developmental genes in HPRT deficiency: clues for Lesch–Nyhan disease?. Human Molecular Genetics. 21(3). 609–622. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026